TL;DR: Maven Bio is a Y Combinator Summer 2023 startup The AI Platform for Life Sciences Intelligence, currently active with a team of 10.
The AI Platform for Life Sciences Intelligence
Last verified:
Maven Bio is a 10-person seed-stage team in Boston building the market intelligence layer for life sciences AI. Three of the top 10 pharma companies are onboarded, and we have 20+ enterprise accounts across pharma, consulting, and investing. Customers report a 40% reduction in low-level analytical work. We are growing fast and heading for a Series A. Our buyers are senior BD, CI, Strategy, and Investing leaders.
Built by LemStudio
Yes. Maven Bio was funded by Y Combinator in the Summer 2023 batch. The AI Platform for Life Sciences Intelligence
Maven Bio is a 10-person seed-stage team in Boston building the market intelligence layer for life sciences AI. Three of the top 10 pharma companies are onboarded, and we have 20+ enterprise accounts across pharma, consulting, and investing. Customers report a 40% reduction in low-level analytical work. We are growing…
Maven Bio was part of Y Combinator's Summer 2023 batch.
Maven Bio has a team of 10 people according to Y Combinator's directory.
Maven Bio is currently listed as Active with a team of 10 in Y Combinator's directory.
Loading interactive view…